To assess the clinical significance of ALDH1A2 expression in patients with prostate cancer, we analyzed 2,510 prostate cancer samples and 1,004 normal prostate specimens from 36 public datasets. This evidence concerns the gene ALDH1A2 and prostate carcinoma.